논문KCI 등재
Challenges and Advancements in Palliative Chemotherapy for Ampullary Adenocarcinoma
1
조회
0
다운로드
0
인용
0
참고문헌
참고문헌 (10)
- O'Connell JB, "Survival after resection of ampullary carcinoma : a national populationbased study", Ann Surg Oncol, 15, pp.1820~1827 (2008)
- Jang DK, "Outcomes of palliative chemotherapy for ampulla of Vater adenocarcinoma : a multicenter cohort study", Gut Liver, 18, pp.729~736 (2024)
- Valle J, "Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer", N Engl J Med, 362, pp.1273~1281 (2010)
- Overman MJ, "Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater", J Clin Oncol, 27, pp.2598~2603 (2009)
- Nappo G, "Ampullary cancer : histological subtypes, markers, and clinical behaviour-state of the art and perspectives", Curr Oncol, 30, pp.6996~7006 (2023)
- Ruemmele P, "Histopathologic features and microsatellite instability of cancers of the papilla of vater and their precursor lesions", Am J Surg Pathol, 33, pp.691~704 (2009)
- Kim HS, "Better outcome of XELOX chemotherapy in patients with advanced intestinal-type adenocarcinoma of the ampulla of Vater", Tohoku J Exp Med, 231, pp.21~28 (2013)
- Chakraborty S, "Genome-derived classification signature for ampullary adenocarcinoma to improve clinical cancer care", Clin Cancer Res, 27, pp.5891~5899 (2021)
- Mafficini A, "Ampulla of Vater carcinoma : sequencing analysis identifies TP53 status as a novel independent prognostic factor and potentially actionable ERBB, PI3K, and WNT pathways gene mutations", Ann Surg, 267, pp.149~156 (2018)
- Patel M, "Treatment approach to adenocarcinoma of the ampulla of Vater", Curr Treat Options Oncol, 22, pp.103~ (2021)
관련 논문AI추천
Chemotherapy for Advanced Gastric Cancer: Slow but Further ProgressYeul Hong Kim대한암학회 · Cancer Research and Treatment2005 · 제37권 제2호Histologic subtyping of ampullary carcinoma for targeted therapy홍승모대한병리학회 · Journal of Pathology and Translational Medicine2021 · 제55권 제3호Outcomes of Palliative Chemotherapy for Ampulla of Vater Adenocarcinoma: A Multicenter Cohort Study박주경, 이윤석, 이희승, 정민규, 황진혁, Chung Hwe Hoon, Jang Dong Kee, Kim So Jeong, Lee Jae Min, Lee Jong-chan, Shin Dong Woo, Yoon Seung Bae거트앤리버 소화기연관학회협의회 · Gut and Liver2024 · 제18권 제4호Is Neoadjuvant Therapy Needed in Patients with Resectable Pancreatic Cancer?Kim Dong Uk거트앤리버 소화기연관학회협의회 · Gut and Liver2022 · 제16권 제1호Current status of chemotherapy for the treatment of advanced biliary tract cancerHiroyuki Isayama, Kazuhiko Koike, Takashi Sasaki, Yousuke Nakai대한내과학회 · The Korean Journal of Internal Medicine2013 · 제28권 제5호Gemcitabine and Infusional 5-Fluorouracil in Advanced Pancreatic Cancer: A Clinical Benefit Response-Oriented Phase II Study김봉석, Chu-Myung Seong, Heung Woo Lee, Ho-Suk Oh, Il-Young Choi, In-Soon Kim, Jung-Hye Choi, Myung-Ju Ahn, Seock-Ah Im, Soon Nam Lee, Yeung Chul Mun, Young-Yeul Lee대한암학회 · Cancer Research and Treatment2003 · 제35권 제3호
이 간행물의 다른 논문 (24건)
From Plate to Stomach: Exploring the Dietary Influence on Gastric Cancer이준행, Kim Tae-Sepp. 551-552Can Epigenetic and Gastric Microbiome Markers Predict the Risk of Helicobacter pylori -Negative Gastric Cancer?Shin Cheol Minpp. 553-555Achieving Sufficient Therapeutic Outcomes of Surgery in Elderly Hepatocellular Carcinoma Patients through Appropriate Selection이한아pp. 556-557Clinical Parameters Work Well as Predictive Factors for Atezolizumab and Bevacizumab Treatment in Hepatocellular CarcinomaSung Pil Soo, Lee Ji Yeonpp. 558-559The Impact of Body Composition on the Prognosis of Nonalcoholic Fatty Liver DiseaseLee Ji Yeonpp. 562-563
